Japan's Shimadzu Corp partners with US-based Sepragen marking entry into biopharma market
Shimadzu will exclusively market and service Sepragen’s products in Japan, South Korea, and Southeast Asia Japan-headquartered Shimadzu Corporation has announced its investment in US-based Sepragen Corporation, a leading company specialising in the …